ZNTL icon

Zentalis Pharmaceuticals

110 hedge funds and large institutions have $1.15B invested in Zentalis Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 35 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

0.05% more ownership

Funds ownership: 112.74%112.79% (+0.05%)

11% less capital invested

Capital invested by funds: $1.29B → $1.15B (-$140M)

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

Holders
110
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$608K
Puts
$471K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
51
$1.11M
52
$1.09M
53
$1.04M
54
$990K
55
$947K
56
$804K
57
$791K
58
$786K
59
$771K
60
$675K
61
$669K
62
$643K
63
$605K
64
$563K
65
$544K
66
$514K
67
$514K
68
$513K
69
$506K
70
$441K
71
$429K
72
$413K
73
$397K
74
$390K
75
$369K